Metabolic profiling reveals key metabolic features of renal cell carcinoma.
about
Metabolism of kidney cancer: from the lab to clinical practiceApplications of metabolomics in cancer researchIn silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).Intratumor Heterogeneity in Primary Kidney Cancer Revealed by Metabolic Profiling of Multiple Spatially Separated Samples within Tumors.Metabolomics of gastric cancer metastasis detected by gas chromatography and mass spectrometry.Metastasis: new perspectives on an old problemDetermination of proline in human serum by a robust LC-MS/MS method: application to identification of human metabolites as candidate biomarkers for esophageal cancer early detection and risk stratificationBioinformatics tools for cancer metabolomics.Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice.The return of metabolism: biochemistry and physiology of the pentose phosphate pathwayA distinct metabolic signature predicts development of fasting plasma glucose.Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells.The proline regulatory axis and cancerProline oxidase promotes tumor cell survival in hypoxic tumor microenvironments.Cancer detection and biopsy classification using concurrent histopathological and metabolomic analysis of core biopsiesApplications of metabolomics for kidney disease research: from biomarkers to therapeutic targets.Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma.Review of mass spectrometry-based metabolomics in cancer research.A metabolic biosignature of early response to anti-tuberculosis treatment.Proline dehydrogenase (oxidase) in cancer.The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans.Metabolomics insights into pathophysiological mechanisms of nephrology.Analytical protocols based on LC-MS, GC-MS and CE-MS for nontargeted metabolomics of biological tissues.Prolidase-proline dehydrogenase/proline oxidase-collagen biosynthesis axis as a potential interface of apoptosis/autophagy.Increased expression of transglutaminase 2 drives glycolytic metabolism in renal carcinoma cells.Metabolic reprogramming in clear cell renal cell carcinoma.Tandem mass spectrometry-based newborn screening strategy could be used to facilitate rapid and sensitive lung cancer diagnosis.Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics.Urine and Serum Metabolomics Analyses May Distinguish between Stages of Renal Cell CarcinomaN-Myc downstream-regulated gene 2 restrains glycolysis and glutaminolysis in clear cell renal cell carcinoma.Renal oncocytoma characterized by the defective complex I of the respiratory chain boosts the synthesis of the ROS scavenger glutathione.Integrative analysis reveals disrupted pathways regulated by microRNAs in cancer.Development and Validation of High Performance Liquid Chromatographic Method for Determination of Gentisic Acid and Related Renal Cell Carcinoma Biomarkers in Urine.Expression parameters of the metabolic pathway genes pyruvate dehydrogenase kinase-1 (PDK-1) and DJ-1/PARK7 in renal cell carcinoma (RCC).Laser desorption/ionization MS imaging of cancer kidney tissue on silver nanoparticle-enhanced target.Metabolomic study of human tissue and urine in clear cell renal carcinoma by LC-HRMS and PLS-DA.Proline oxidase silencing induces proline-dependent pro-survival pathways in MCF-7 cells.
P2860
Q24600512-7CBBA356-0252-4A66-9995-96BBF8E6384FQ24600728-05372900-1667-4013-8C3E-86C36B4F101DQ33701036-7BC9793C-BFB5-4187-89A5-404EBF4D3AE2Q33715755-B8470BCE-3B0D-4394-977F-55184DC24B2EQ34406520-79A1A56B-0A17-4898-8F6A-60F916D9ED59Q34639530-1B51645C-32F7-490E-8967-37EA56592F82Q35132600-8FCCAB72-6440-4C4A-90E9-B7B3E626E801Q35163111-6129AA5B-986B-4B90-8B3A-D1740AF0D432Q35184821-ED0E0CA2-0FC8-4BEB-8DFE-1B69924D6A05Q35752267-39953DA2-612C-46F3-B8D1-B0C06B89D491Q35819638-1029DB5D-21C1-4371-A16E-F07DBBCB11FCQ35860727-DC6FEA7F-0263-4998-A5F4-60CFC09D8D74Q36050265-9250DA4D-29EC-4E08-AC36-D885BC901F1FQ36101103-C7A57002-F2F7-464E-B368-154A3CAFBB1DQ36245147-9B7910BA-4C6C-441E-9AC7-BED014AE860BQ36906135-0C4B4690-A4A6-4F8F-B698-AA61B8CA4A76Q37421650-FBD9569C-EC90-4EBC-B88E-EEDC9678033AQ37550758-2A6F9986-1BC8-4E52-BC7A-A2647DBC17E6Q37569320-85F985AD-0962-4014-91C3-9A396C38F349Q38034142-F70592E7-3CD4-425E-9D49-2BF82E1BA292Q38050514-5FE87961-94CF-41DA-AC5B-C909F9491306Q38161822-66B83F91-17BD-410C-B0A5-D1C949C3950BQ38235440-05B3007A-08F4-47DB-A390-B1C7267C9F25Q38797107-604E0114-78F7-4360-8974-A966FD826E98Q39014146-C15940B6-9D3A-47A4-999B-B7BFB333BFE9Q39290307-6244D180-5B7C-4F52-ABDF-213ECFCF1043Q40878024-814FE986-E394-40EE-B33C-E20DFFCACF69Q42140873-6B4682DC-B7DD-44BD-BDBC-457BF804A963Q42293369-88ECAC43-B579-4328-9540-9986B95251D8Q46077517-E828DB10-DF50-4D57-BFF5-076BA225EE6DQ47131093-0E1919F8-638B-47A4-A523-639ACFBB3ACCQ47205145-724705C6-EC7F-48E3-9FAC-EF6C80E61B76Q47778959-EDB175BA-E889-45A6-9B00-8967478122FDQ47834178-61BEAE4F-9D4B-4AAA-94E5-B962FAE59F2BQ49846789-5C5B4B9A-B341-4B5E-8B82-85575D145C2BQ54964002-0E533DCA-810E-40BE-BAF4-CD202F160423Q55101153-F448BB82-523B-4108-8B2A-D126DFB7ACF5
P2860
Metabolic profiling reveals key metabolic features of renal cell carcinoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Metabolic profiling reveals key metabolic features of renal cell carcinoma.
@ast
Metabolic profiling reveals key metabolic features of renal cell carcinoma.
@en
Metabolic profiling reveals key metabolic features of renal cell carcinoma.
@nl
type
label
Metabolic profiling reveals key metabolic features of renal cell carcinoma.
@ast
Metabolic profiling reveals key metabolic features of renal cell carcinoma.
@en
Metabolic profiling reveals key metabolic features of renal cell carcinoma.
@nl
prefLabel
Metabolic profiling reveals key metabolic features of renal cell carcinoma.
@ast
Metabolic profiling reveals key metabolic features of renal cell carcinoma.
@en
Metabolic profiling reveals key metabolic features of renal cell carcinoma.
@nl
P2093
P2860
P50
P1476
Metabolic profiling reveals key metabolic features of renal cell carcinoma.
@en
P2093
Carsten Kempkensteffen
Cornelia Weikert
Gareth Catchpole
Hans Krause
Joachim Selbig
Kurt Miller
Manfred Johannsen
Steffen Weikert
P2860
P304
P356
10.1111/J.1582-4934.2009.00939.X
P577
2011-01-01T00:00:00Z